Brief: China Grand Pharmaceutical And Healthcare Reached An Exclusive Product Licensing Agreement
03/06/2021 16:08
June 3 (Reuters) - China Grand Pharmaceutical and Healthcare
Holdings Ltd 0512.HK :
* CHINA GRAND PHARMACEUTICAL AND HEALTHCARE - REACHED AN
EXCLUSIVE PRODUCT LICENSING AGREEMENT WITH FORMOSA
PHARMACEUTICALS, INC
* CHINA GRAND PHARMACEUTICAL AND HEALTHCARE - UNDER
AGREEMENT, CO
WILL OBTAIN EXCLUSIVE DEVELOPMENT AND COMMERCIALIZATION RIGHTS
OF APP13007
* CHINA GRAND PHARMACEUTICAL AND HEALTHCARE-CO TO GET RIGHTS
IN
MAINLAND CHINA, HONG KONG & MACAU WITH A MILESTONE PAYMENT OF
NOT MORE THAN USD9.5 MILLION
Further company coverage: 0512.HK
(Reuters.briefs@thomsonreuters.com)
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement